BBSRC invests £48 million in lifelong health research at Babraham Institute
The £48 million strategic investment will advance research on the mechanisms that maintain the health of our cells, tissues and organs across the life course.
Following a five-year review by the Biotechnology and Biological Sciences Research Council (BBSRC), the Babraham Institute will receive £48 million to support core research across epigenetics, immunology and cell signalling.
Over the next four years, BBSRC’s investment will drive key research on the mechanisms that maintain the health of our cells, tissues and organs across the whole life course.
Published on the 10th of May 2024. Read the entire news report here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (4 novembre 2024). BBSRC invests £48 million in lifelong health research at Babraham Institute. ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/12m6u
